| Clinical data | |
|---|---|
| Other names | (2Z,4S,4aS,5aS,6S,12aS)-4-Dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.010.938 |
| Chemical and physical data | |
| Formula | C27H33N3O8 |
| Molar mass | 527.574 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Rolitetracycline is atetracycline antibiotic.[1] Tetracycline isN-Mannich baseprodrug that is prepared fromtetracycline by condensation withpyrrolidine andformaldehyde to produce rolitetracycline.[2] Rolitetracycline is used as an antibacterial drug, a protein synthesis inhibitor, an antiprotozoal drug and a prodrug.[2][3]
This systemicantibiotic-related article is astub. You can help Wikipedia byadding missing information. |